---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-005383"
form_type: "8-K"
ticker: null
cik: "0001537561"
company_name: "Arch Therapeutics, Inc."
filed_at: "2025-02-07T23:59:59+00:00"
generated_at: "2026-05-27T00:54:11.011202+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Arch Therapeutics CFO Abrams resigns; CEO Norchi assumes additional officer roles

## Summary
- Michael S. Abrams resigned as CFO and Treasurer effective Feb 3, 2025, and waived contract claims.
- CEO Terrence W. Norchi appointed Principal Accounting Officer and Treasurer same day.
- Norchi continues as CEO, Chairman, President, and Secretary of the company.

## SEC filing metadata
- accession: 0001493152-25-005383
- form_type: 8-K
- cik: 0001537561
- company_name: Arch Therapeutics, Inc.
- filed_at: 2025-02-07T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1537561/000149315225005383/0001493152-25-005383-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1537561/000149315225005383/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-005383
- JSON: https://secwatch.observer/filing/0001493152-25-005383.json
- Plain text: https://secwatch.observer/filing/0001493152-25-005383.txt

## Key facts
- Executive change
  Michael S. Abrams resigned as Chief Financial Officer and Treasurer at Arch Therapeutics, Inc..
  - Action: resigned
  - Role: Chief Financial Officer and Treasurer
  source text: On February 3, 2025, Michael S. Abrams, Chief Financial Officer and Treasurer of Arch Therapeutics, Inc. (the “Company”), resigned from his positions with the Company, effective immediately, and has waived any potential rights or claim to any financial obligations under his employment contract.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1537561/000149315225005383/0001493152-25-005383-index.htm
- Executive change
  Terrence W. Norchi was appointed as Principal Accounting Officer and Treasurer at Arch Therapeutics, Inc..
  - Action: appointed
  - Role: Principal Accounting Officer and Treasurer
  source text: Effective February 3, 2025, the Company has appointed Terrence W. Norchi, who serves as the Company’s Chief Executive Officer, Chairman, President and Secretary, to the roles of Principal Accounting Officer and Treasurer.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1537561/000149315225005383/0001493152-25-005383-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.